Idexx Laboratories Inc (IDXX): Depreciation & Amortization
$145.18M
Year ended 2025-12-31
$154.08M
Trailing 12 months to 2026-06-30
+9.1%
3-year compound annual growth
+8.6%
5-year compound annual growth
+7.7%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $145.18M | +11.7% | 2026-02-20, From 2025-01-01 |
| 2024-12-31 | $129.94M | +13.1% | 2026-02-20, From 2024-01-01 |
| 2023-12-31 | $114.91M | +2.7% | 2026-02-20, From 2023-01-01 |
| 2022-12-31 | $111.90M | +7.0% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $104.60M | +9.0% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $96.00M | +9.1% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $88.01M | +5.8% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $83.18M | 0.0% | 2021-02-12, From 2018-01-01 |
| 2017-12-31 | $83.14M | +6.3% | 2020-02-14, From 2017-01-01 |
| 2016-12-31 | $78.22M | +13.4% | 2019-02-15, From 2016-01-01 |
| 2015-12-31 | $68.96M | +17.1% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $58.89M | +7.9% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $54.60M | +4.2% | 2016-02-17, From 2013-01-01 |
| 2012-12-31 | $52.41M | +8.7% | 2015-02-17, From 2012-01-01 |
| 2011-12-31 | $48.20M | +4.9% | 2014-02-18, From 2011-01-01 |
| 2010-12-31 | $45.96M | -7.7% | 2013-02-19, From 2010-01-01 |
| 2009-12-31 | $49.77M | +3.7% | 2012-02-17, From 2009-01-01 |
| 2008-12-31 | $47.98M | n/a | 2011-02-22, From 2008-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $145.18M | +11.7% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $442.00M | -2.5% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $70.10M | +8.5% |
| Neogen Corp (NEOG) | 2026-05-31 | $116.30M | -2.7% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $53.70M | -12.3% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $9.77M | -5.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $6.34M | -3.6% |
| Immucell Corp (ICCC) | 2025-12-31 | $2.78M | +2.0% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $112.0K | +21.7% |
Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗